| |
| |
|
| Insider
Information: |
Erck Stanley C |
| Relationship: |
President and CEO, Dir... |
| City: |
Gaithersburg |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
84,825 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$229,651 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
84,825 |
|
|
| Total
Value |
$229,651 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -200.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biocryst Pharmaceuticals Inc |
BCRX |
Director |
2018-11-28 |
48,333 |
2009-03-12 |
0 |
Premium* |
|
|
Novavax Inc |
NVAX |
President and CEO, Dir... |
2022-12-14 |
36,492 |
2011-08-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
48 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2020-10-01 |
4 |
AS |
$108.57 |
$217 |
D/D |
(2) |
20,494 |
0 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2020-09-28 |
4 |
D |
$111.18 |
$148,759 |
D/D |
(1,338) |
73,268 |
0 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2020-03-08 |
4 |
D |
$12.48 |
$24,860 |
D/D |
(1,992) |
20,494 |
0 |
- |
|
| NVAX |
Novavax Inc |
CEO and President |
• • – |
2016-01-31 |
4 |
B |
$4.38 |
$9,075 |
D/D |
2,072 |
103,057 |
2.81 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2022-09-26 |
4 |
D |
$18.87 |
$41,137 |
D/D |
(2,180) |
31,846 |
0 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2022-12-14 |
4 |
D |
$17.23 |
$39,974 |
D/D |
(2,320) |
36,492 |
0 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2020-09-26 |
4 |
D |
$113.56 |
$276,405 |
D/D |
(2,434) |
24,606 |
0 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2021-09-26 |
4 |
D |
$248.16 |
$784,682 |
D/D |
(3,162) |
23,879 |
0 |
- |
|
| NVAX |
Novavax Inc |
CEO and President |
• • – |
2015-07-31 |
4 |
B |
$2.28 |
$7,312 |
D/D |
3,207 |
100,985 |
2.81 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2021-12-14 |
4 |
D |
$168.43 |
$566,935 |
D/D |
(3,366) |
27,480 |
0 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2020-09-29 |
4 |
AS |
$106.22 |
$443,267 |
D/D |
(4,112) |
32,727 |
0 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2020-03-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,072 |
22,486 |
0 |
- |
|
| NVAX |
Novavax Inc |
CEO and President |
• • – |
2015-01-31 |
4 |
B |
$2.28 |
$13,958 |
D/D |
6,122 |
97,778 |
2.81 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2020-09-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,546 |
27,040 |
0 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2021-09-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,546 |
27,041 |
0 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2022-09-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,546 |
34,026 |
0 |
- |
|
| NVAX |
Novavax Inc |
CEO and President |
• • – |
2014-07-31 |
4 |
B |
$2.28 |
$15,477 |
D/D |
6,788 |
91,656 |
2.81 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2022-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,966 |
38,812 |
0 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2021-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,967 |
30,846 |
0 |
- |
|
| BCRX |
Biocryst Pharmaceuticals ... |
Director |
• • – |
2018-11-28 |
4 |
OE |
$1.49 |
$12,416 |
D/D |
8,333 |
48,333 |
0 |
- |
|
| NVAX |
Novavax Inc |
CEO and President |
• • – |
2014-03-25 |
4/A |
B |
$4.27 |
$42,698 |
D/D |
10,000 |
84,868 |
2.81 |
- |
|
| NVAX |
Novavax Inc |
CEO and President |
• • – |
2014-03-25 |
4 |
S |
$4.27 |
$42,698 |
D/D |
(10,000) |
84,868 |
0 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2020-09-28 |
4 |
D |
$111.18 |
$1,270,676 |
D/D |
(11,429) |
61,839 |
0 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2014-01-31 |
4 |
B |
$2.29 |
$27,178 |
D/D |
11,868 |
74,868 |
2.81 |
- |
|
| NVAX |
Novavax Inc |
President and CEO |
• • – |
2020-09-30 |
4 |
AS |
$107.56 |
$1,348,200 |
D/D |
(12,231) |
20,496 |
0 |
- |
|
48 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
